GM ‘designer babies’: breakthrough or nightmare?
By Dave King,
Red Pepper
| 12. 06. 2021
Only a global ban on human genetic engineering can prevent a new era of eugenics from emerging.
Hongjie mao, CC BY-SA 4.0, via Wikimedia Commons
In late 2018, when He Jiankui announced that he had created the world’s first genetically modified (GM) babies, part of the worldwide outrage was motivated by the hope that we would not have to deal with this issue for at least ten years. Since then, eugenics has reared its ugly head in the experience of minority ethnic and disabled people during the pandemic, and with the revelations that women were being sterilised without their knowledge in one of Donald Trump’s ICE detention centres in Georgia. In Britain, we had the prime minister’s then chief adviser, Dominic Cummings, trying to appoint outspoken eugenicists to advisory roles in number 10 and to head up his pet Advanced Research and Invention Agency.
Eugenics is here and now; in fact, it never went away. That is why nearly all industrialised countries put in place legal bans on the genetic engineering of human beings in the 1990s or earlier. But despite that, scientific establishment bodies, which cannot countenance the idea of banning any type of...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...